https://www.biohealthcapital.com Advancing Science. Accelerating Innovation. Fri, 13 Sep 2024 18:14:06 +0000 en-US hourly 1 https://wordpress.org/?v=5.7.15 https://www.biohealthcapital.com/news/be-bold-cutting-edge-lab-space-available-at-the-gateway-of-the-nih-delivering-summer-2021/ http://www.biohealthcapital.com/?p=2294 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Mon, 18 Mar 2019 12:43:14 +0000 Cutting Edge Lab Space Available The NIH is the cornerstone to the world scientific community and is the largest life sciences engine in the US. Bethesda Bio gives life science...]]> https://www.biohealthcapital.com/news/these-3-tech-investors-are-the-most-active-in-the-dmv-report-technical-ly-dc/ http://www.biohealthcapital.com/?p=2292 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Mon, 18 Mar 2019 12:34:34 +0000 Three investment firms topped the list of local tech investors in the DMV region according to CB Insights‘ report, The United States of Venture Capital. View Article]]> https://www.biohealthcapital.com/news/bhi-entrepreneur-in-residence-feedback-session-march-20th/ http://www.biohealthcapital.com/?p=2286 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Mon, 18 Mar 2019 12:34:30 +0000 Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan?  Sign up by noon 3/19 to schedule your feedback...]]> https://www.biohealthcapital.com/news/state-department-awards-emergent-biosolutions-contract-for-chemical-warfare-countermeasures-homeland-preparedness-news/ http://www.biohealthcapital.com/?p=2282 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Mon, 18 Mar 2019 12:34:29 +0000 Emergent BioSolutions announced today that the company has signed a deal with the U.S. Department of State to establish a supply chain for certain medical countermeasures that address chemical warfare...]]> https://www.biohealthcapital.com/news/strong-interest-in-non-dilutive-funding-programs/ http://www.biohealthcapital.com/?p=2284 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Mon, 18 Mar 2019 12:34:29 +0000 More than 120 people registered for last week’s SBIR Workshop organized by BioHealth Innovation in partnership with Launch Workplaces and support from TEDCO and NIH FCU.   The event featured...]]> https://www.biohealthcapital.com/news/successful-marketing-pr-strategies-for-your-startup-44/ http://www.biohealthcapital.com/uncategorized/successful-marketing-pr-strategies-for-your-startup-44/ scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Thu, 14 Mar 2019 20:28:58 +0000 PR and Marketing – What’s the difference? How do you establish your brand? Are their tips for marketing on a tight budget? What should an effective marketing plan include? How...]]> https://www.biohealthcapital.com/news/sonavex-receives-fda-510k-clearance-for-echosure/ http://www.biohealthcapital.com/uncategorized/sonavex-receives-fda-510k-clearance-for-echosure/ scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Thu, 14 Mar 2019 20:28:57 +0000 Sonavex, Inc., a privately held medical device company focused on empowered patient care, announced today that on March 8, 2019 it received 510(k) clearance from the U.S. Food and Drug...]]> https://www.biohealthcapital.com/news/hopkins-professors-receive-grants-to-commercialize-research-maryland-daily-record/ http://www.biohealthcapital.com/uncategorized/hopkins-professors-receive-grants-to-commercialize-research-maryland-daily-record/ scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Thu, 14 Mar 2019 20:28:45 +0000 Four Johns Hopkins professors received grants through a fund created to help faculty put their research on a path to commercialization. The professors received grants between $25,000 and $100,000 from...]]> https://www.biohealthcapital.com/news/chinese-born-legislator-makes-history-in-us-local-politics/ http://www.biohealthcapital.com/uncategorized/chinese-born-legislator-makes-history-in-us-local-politics/ scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Thu, 14 Mar 2019 20:28:43 +0000   One woman is making her mark at the highest level of U.S. local politics. She was born in China and successfully carved her path all the way to the...]]> https://www.biohealthcapital.com/news/counties-support-kirwan-blueprint-bill-as-worthy-first-steps-conduit-street/ http://www.biohealthcapital.com/uncategorized/counties-support-kirwan-blueprint-bill-as-worthy-first-steps-conduit-street/ scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Thu, 14 Mar 2019 20:28:40 +0000 On Wednesday, MACo Legislative Committee members Craig Rice (Montgomery), Jan Gardner (Frederick), and Laura Price (Talbot) joined Executive Director Michael Sanderson in support of SB 1030 The Blueprint for Maryland’s...]]> https://www.biohealthcapital.com/news/galen-robotics-wins-biohealth-capital-region-3rd-annual-crab-trap-competition/ http://www.biohealthcapital.com/?p=1751 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Tue, 03 Jul 2018 13:37:57 +0000 Galen Robotics, a Johns Hopkins University spinout, was chosen from five finalists as the company with the most commercial potential by judges at the 3rd Annual Crab Trap Competition. This year’s...]]> https://www.biohealthcapital.com/news/tedco-new-funding-programming-underserved-founders-technical-ly-baltimore/ http://www.biohealthcapital.com/?p=1748 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Tue, 03 Jul 2018 13:35:14 +0000 TEDCO plans to provide funding and business-building programming to entrepreneurs from groups who are often overlooked by investors through a new fund that will begin this fall.]]> https://www.biohealthcapital.com/news/greater-washington-partnership-teaming-universities-build-set-regional-tech-credentials-washington-business-journal/ http://www.biohealthcapital.com/?p=1745 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Tue, 03 Jul 2018 13:32:22 +0000 The Greater Washington Partnership, an alliance of local CEOs, is launching a formal collaboration program with a swath of regional universities — part of an effort to spur the development...]]> https://www.biohealthcapital.com/news/can-bacteria-slaying-viruses-defeat-antibiotic-resistant-infections-new-u-s-clinical-center-aims-find-science-aaas/ http://www.biohealthcapital.com/?p=1742 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Tue, 03 Jul 2018 13:31:24 +0000 One piece of good news can make all the difference. In the fight against antibiotic-resistant infections, a decades-old approach based on bacteria-slaying viruses called phages has been sidelined by technical...]]> https://www.biohealthcapital.com/news/qiagen-announces-broadening-genereader-ngs-system-applications-hereditary-disease-analysis-business-wire/ http://www.biohealthcapital.com/?p=1739 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Tue, 03 Jul 2018 13:30:13 +0000 QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today introduced seamless next-generation sequencing (NGS) solutions for a wide range of hereditary diseases on the GeneReader NGS System, the complete Sample...]]> https://www.biohealthcapital.com/news/rockville-employers-rank-high-top-workplace-2018-list-rockville-md-patch/ http://www.biohealthcapital.com/?p=1736 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Tue, 03 Jul 2018 13:28:55 +0000 Two Rockville employers are among the top workplaces in the region, according to The Washington Post’s newest ranking.]]> https://www.biohealthcapital.com/news/greater-baltimores-top-nih-grant-recipients-include-johns-hopkins-kennedy-krieger-baltimore-business-journal/ http://www.biohealthcapital.com/?p=1734 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Tue, 03 Jul 2018 13:28:07 +0000 Johns Hopkins University is again the top NIH grant recipient in Greater Baltimore in 2017, with a total grant value of $651.8 million last year. The university also led all...]]> https://www.biohealthcapital.com/news/campus-director-leslie-weber-inducted-chair-montgomery-county-chamber-commerce-news-johns-hopkins-university-montgomery-county-campus/ http://www.biohealthcapital.com/?p=1731 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Tue, 03 Jul 2018 13:27:05 +0000 Leslie Weber was inducted in June as chair of the board of directors of the Montgomery County Chamber of Commerce. Weber is director of the Johns Hopkins University Montgomery County...]]> https://www.biohealthcapital.com/news/gel-e-expands-otc-label/ http://www.biohealthcapital.com/?p=1728 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Tue, 03 Jul 2018 13:25:59 +0000 gel-e Inc., announces the 510(k) clearance of gel-e FLEX by the U.S. Food and Drug Administration (FDA) for the over-the-counter (OTC) use of its first flowable hemostat. This new clearance...]]> https://www.biohealthcapital.com/news/cosmosid-top-performer-janssens-mosaic-strain-challenge-precisionfdas-cfsan-pathogen-detection-challenge-cosmosid/ http://www.biohealthcapital.com/?p=1725 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Tue, 03 Jul 2018 13:24:53 +0000 CosmosID a bioinformatics provider and NGS service laboratory announced that the company’s cloud-based bioinformatics platform for microbiome analysis has received the highest score in the strain-level microbial profiling category of the Mosaic...]]> https://www.biohealthcapital.com/partners/childrens-national-health-system/ http://www.biohealthcapital.com/?p=1671 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Thu, 18 Jan 2018 16:34:58 +0000 Children’s National Hospital, based in Washington, D.C., celebrates 150 years of pediatric care, research and commitment to community. Volunteers opened the hospital in 1870 with 12 beds for children displaced...]]> https://www.biohealthcapital.com/news/banner-year-greater-washington-venture-capital-tops-1-5b-2017/ http://www.biohealthcapital.com/?p=1618 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Tue, 16 Jan 2018 16:53:21 +0000 Greater Washington had its second-biggest venture funding year in at least a decade in 2017, with startups across the metro area raking in more than $1.55 billion.]]> https://www.biohealthcapital.com/news/15-companies-graduate-umbcs-bwtech-ready-grow/ http://www.biohealthcapital.com/?p=1615 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Tue, 16 Jan 2018 16:51:26 +0000 More than 110 companies have graduated since bwtech@UMBC began offering incubation services in 1989.]]> https://www.biohealthcapital.com/news/tai-diagnostics-raises-10m-inks-deal-united-therapeutics/ http://www.biohealthcapital.com/?p=1612 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Tue, 16 Jan 2018 16:50:22 +0000 TAI Diagnostics said earlier this week that it had closed a $10 million round of funding and forged a new partnership with United Therapeutics (NASDAQ: UTHR).]]> https://www.biohealthcapital.com/news/emergent-biosolutions-initiates-phase-2-clinical-study-evaluate-flu-igiv-treat-serious-influenza-infection/ http://www.biohealthcapital.com/?p=1610 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Tue, 16 Jan 2018 16:48:40 +0000 Emergent BioSolutions Inc. (NYSE:EBS) today announced the initiation of a Phase 2 dose ranging study to evaluate the safety, pharmacokinetics, and clinical benefit of FLU-IGIV, the company’s anti-influenza immune globulin...]]> https://www.biohealthcapital.com/news/new-money-8-d-c-area-startups-raised-capital-december/ http://www.biohealthcapital.com/?p=1607 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Tue, 16 Jan 2018 16:48:04 +0000 In covering the D.C. innovation economy comes the inevitable: funding news. Trust us, there’s a lot of it floating around the D.C. metro area. Here’s a roundup of all of...]]> https://www.biohealthcapital.com/news/virginia-bio-welcomes-new-members-board-directors/ http://www.biohealthcapital.com/?p=1605 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Tue, 16 Jan 2018 16:46:19 +0000 Virginia Bio, the premier statewide non-profit association representing the life science industry in the Commonwealth of Virginia, has elected two new members to their Board of Directors for a term...]]> https://www.biohealthcapital.com/news/d-c-area-technology-investment-soared-2017-early-stage-firms-still-struggle/ http://www.biohealthcapital.com/?p=1636 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Sun, 14 Jan 2018 13:58:26 +0000 Venture capitalists poured $1.55 billion into D.C. area technology start-ups last year, an industry report found, as a handful of so-called megadeals propelled the region to a six-year high for...]]> https://www.biohealthcapital.com/news/personal-genome-diagnostics-closes-75-million-financing-round/ http://www.biohealthcapital.com/?p=1643 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Thu, 04 Jan 2018 14:01:57 +0000 Personal Genome Diagnostics, a Baltimore-based cancer diagnostics company, has raised $75 million to expand access to genomic testing for cancer patients.]]> https://www.biohealthcapital.com/news/neximmune-raises-23-million-advance-endogenous-cellular-immunotherapy-clinical-development/ http://www.biohealthcapital.com/?p=1639 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2019/03/bethesda-bio-8280-wisconsin-image.png"/> Tue, 02 Jan 2018 14:00:30 +0000 NexImmune, an emerging leader in the field of antigen-directed immunotherapy, announced the closing of a Series A financing co-led by new investor ArrowMark Partners and existing investor Barer & Son...]]>